Express Scripts

Q4 Results Q/Q Comparison:

  • Revenue decreased 5% to $24.9B
  • GAAP diluted EPS increased 107% to $2.34
    • Adjusted EPS increased 21% to $1.88
  • GAAP net income increased 85% to $1.43B
    • Adjusted net income increased 8% to $1.15B
  • Operating cashflow decreased 22% to $2.25B
  • Adjusted claims decreased 6% to 354.9 million
  • Adjusted EBITDA per adjusted claim increased 14% to $5.79

Full-year 2016 Results Q/Q Comparison:

  • Revenue decreased 1% to $100.3B
  • GAAP diluted EPS increased 51% to $5.39
    • Adjusted EPS increased 16% to $6.39
  • GAAP net income increased 37% to $3.40B
    • Adjusted net income increased 5% to $4.03B
  • Operating cashflow increased 1% to $4.92B
  • Adjusted claims decreased 2% to 1,407.6 million
  • Adjusted EBITDA per adjusted claim increased 6% to $5.16
  • Repurchased $5.6B worth of stock, retiring over 10% of outstanding shares
  • Ended year with cash of $3.1B and debt of $15.6B (net debt-to-EBITDA of 1.7x)

2017 Guidance:

  • Full-year adjusted EPS guidance range to $6.82 - $7.02 (represents growth of 7% to 10%)
  • 2016 total adjusted claims of 1.375B to 1.425B
  • Operating cashflow of $4.7B to $5.2B
  • Capital expenditures of approximately $300M
  • Free cashflow of $4.4B to $4.9B

Stock Price: $70
Market Capitalization: $43 billion

February 14, 2017

 

 

 


 


 

Menu byMilonic